Skip to content

Prediction of the Severity of Female SUI by Measuring New Static and Dynamic Ultrasound Parameters of the Urethra

Prediction of the Severity of Female SUI by Measuring New Static and Dynamic Ultrasound Parameters of the Urethra

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03566121
Acronym
PRESIUS
Enrollment
50
Registered
2018-06-21
Start date
2018-07-10
Completion date
2020-07-13
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incontinence, Urinary

Brief summary

This study aims to evaluate the correlation of the ultrasonic functional length of the urethra and the incontinence urinary disorder (IUD). The goal is to predict the severity of the IU by measuring new static and dynamic ultrasound parameters of the urethra.

Detailed description

The urinary incontinence is a disorder which affects 25 to 45% of women. Nowadays, the role of urethral tissue in IUD is not explored although well viewed in perineal ultrasound. Our actual knowledge demonstrates that urodynamic ultrasound is reliable to establish the bladder neck mobility. And the posterior urethral wall mobility was often associated to the stress urinary incontinence. Two elements appeared to indicate the elasticity of the urethral environment: functional length urethral variation and urethral closure angle variation during Valsalva manoeuvres compared to rest. This study aims to evaluate the correlation of the ultrasonic functional length of the urethra and the incontinence urinary disorder for the purpose to predict the severity of this syndrome.

Interventions

OTHERPelvic ultrasound / Urodynamic ultrasound

Gynecological consultation: calculating the score ICI-Q Ultrasound consultation: pelvic ultrasound Urodynamic ultrasound during a Valsalva manoeuvers

Sponsors

CMC Ambroise Paré
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* All patients aged over 18 years addressed to pelvic ultrasound

Exclusion criteria

* Pregnant * Post-partum (under 6 month of childbirth) * Operated for a genitourinary prolapse or/and urinary incontinence * Utero vaginal symptomatic prolapse * Overactive bladder ± UI by * Dysuria * Severe deep pelvic endometriosis * Respiratory failure (Unable to perform the Valsalva manoeuvres) * History of pelvic cancer * Unable to understand the information communicated

Design outcomes

Primary

MeasureTime frameDescription
Measurement of ultrasonic urethral lengthFrom 3 to 11 days after gynecological consultationLT total length LF functional length LE funnel urethral length Measurement of the angle between proximal and distal urethra

Countries

France

Contacts

PRINCIPAL_INVESTIGATORGeorges BADER, MD

CMC Hartmann

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026